Last updated 2026-07-26
- Acquired by Mori Arkin, Jul 2014
- Raised $33.1M Follow-on PO, Mar 2026
- Raised $75M IPO, Feb 2018
Total raised
$221.7M
Last: Undisclosed Round 2008-11
Stage
Public
Founded
1997
Headcount
48
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Sol-Gel Technologies is an experienced dermatology company that leverages innovative approaches to develop advanced treatments for patients with severe skin conditions. They focus on skin diseases that demand therapeutic innovation, aiming to bridge the gap between existing treatments and transformative solutions for patients with rare skin conditions. The company utilizes a proprietary, silica-based microencapsulation technology platform.
Funding history · 10 rounds · $221.7M total
2026-03
Follow-on PO
$33.1M
2023-05
Follow-on PO
$22.8M
2023-01
Follow-on PO
$12.8M
2022-04
Follow-on PO
$23.0M
2020-02
Follow-on PO
$23.0M
2019-08
Follow-on PO
$10.0M
2019-05
Follow-on PO
$15.0M
2018-02
IPO
$75.0M
2008-10
Undisclosed Round
Undisclosed
★ Medica Venture Partners
2006-05
Undisclosed Round
$7.0M
★ JVP
Headcount over time
From 37 (2018-09) to 28 (2026-07) · -9 (-24%) · 47 points · source: Finder history + radar grounding
Q&A
- What is Sol-Gel Technologies' primary focus?
- Sol-Gel Technologies is a dermatology company that develops advanced treatments for patients with severe skin conditions, utilizing a proprietary, silica-based microencapsulation technology platform.
- When was Sol-Gel Technologies acquired and by whom?
- Sol-Gel Technologies was acquired by Mori Arkin in July 2014.
- What was the amount raised in Sol-Gel Technologies' Public Offering in May 2023?
- In May 2023, Sol-Gel Technologies raised $22,800,000 through a Public Offering.
- What was the amount raised in Sol-Gel Technologies' Public Offering in January 2023?
- In January 2023, Sol-Gel Technologies raised $12,800,000 through a Public Offering.
- What was the amount raised in Sol-Gel Technologies' Public Offering in April 2022?
- In April 2022, Sol-Gel Technologies raised $23,000,000 through a Public Offering.
- Which products developed by Sol-Gel Technologies are marketed by Galderma in the US?
- Sol-Gel Technologies successfully developed topical drugs Twyneo and Epsolay for the treatment of acne and inflammatory lesions of rosacea, both of which have been marketed in the US by Galderma since 2022.
- What was the amount raised in Sol-Gel Technologies' Public Offering in February 2020?
- In February 2020, Sol-Gel Technologies raised $23,010,977 through a Public Offering.
- What was the amount raised in Sol-Gel Technologies' Public Offering in August 2019?
- In August 2019, Sol-Gel Technologies raised $10,000,000 through a Public Offering.
- What was the amount raised in Sol-Gel Technologies' Public Offering in May 2019?
- In May 2019, Sol-Gel Technologies raised $15,000,000 through a Public Offering.
- What was the amount raised in Sol-Gel Technologies' Public Offering in February 2018?
- In February 2018, Sol-Gel Technologies raised $75,000,000 through a Public Offering.
Team · 2
Alon Seri-Levy
Founder · Co-Founder & CEO
David Avnir
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryDrugs Discovery & Development
Technologies
Materials & SubstancesNanomaterialsBiologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsdermatologymedicationskin-caretopical-treatmentnanotechnologydrug-deliverychronic-patientsacnelife-sciencescosmetic-companiespharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sol-gel.com/ |
|---|---|
| linkedin.com/company/1117260 | |
| Wikidata | wikidata.org/wiki/Q106411767 |
Identifiers & details
| Legal name | Sol-Gel Technologies Ltd. |
|---|---|
| Founded | 1997 |
| Employees (exact) | 48 |
| Market cap | $117.4M |
| Status reason | Acquired by Mori Arkin on Jul, 2014 |
| Wikidata QID | Q106411767 |
Acquisitions & public offerings
Acquired by Mori Arkin 2014-07
Radar intelligence
Patents
| EPO | 97 |
|---|
Web history (Wayback)
| Domain | sol-gel.com |
|---|
Wikidata
| QID | Q106411767 |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512544693 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 1997-10-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2019 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | גולדה מאיר 7 נס ציונה |